Robust and sustained efficacy in both adult PKD patients up to 30 months post-RP-L301; first pediatric patient results suggest efficacy similar to adult cohort with initial greater than five-point increase in hemoglobin Sustained genetic correction observed in eight of 12 evaluable Fanconi Anemia patients, and phenotypic correction and concomitant hematologic […]
Other News
InspireMD Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
TEL AVIV, Israel and MIAMI, May 18, 2023 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that, in connection with the appointment of Shane Gleason as General Manager of North America and VP of Global Marketing […]
Impulse Dynamics Announces First Implant for CCM-D™ Clinical Trial
World’s First Device Combining CCM Therapy With an ICD in a Single Rechargeable Implant That Treats Both Heart Failure Symptoms and Sudden Cardiac Death MARLTON, N.J., May 18, 2023 (GLOBE NEWSWIRE) — Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure, […]
NEW LATE-BREAKING DATA REINFORCE THE BENEFITS OF ABBOTT’S TRICLIP™ DEVICE FOR PEOPLE WITH TRICUSPID VALVE DISEASE
Data presented at EuroPCR 2023 build on prior study results demonstrating TriClip is a safe and effective therapy to treat leaky tricuspid valves Findings from the largest real-world dataset for tricuspid repair show device reduces tricuspid regurgitation and improves quality of life ABBOTT PARK, Ill., May 17, 2023 — Abbott […]
Abbott Receives FDA Clearance for Assert-IQ™ Insertable Cardiac Monitor to Help Doctors Monitor People’s Heart Rhythms Long-Term
Abbott’s Assert-IQ offers the world’s longest battery life† for an insertable cardiac monitor (ICM) The latest addition to Abbott’s portfolio of connected health devices, the Assert-IQ ICM offers long-term monitoring and remote programming to improve connectivity to patients The device provides continuous monitoring for abnormal heart rhythms while offering tools […]
FDA Approves Next Generation MicroPort CRM AlizeaTM and CeleaTM Pacemaker Systems
Alizea™ and Celea™ are the world’s longest-lasting pacemakers for their size on the market today1 AlizeaTM and CeleaTM Pacemaker Systems feature AutoMRI™ Mode and Bluetooth®2 Connectivity May 18, 2023 08:00 AM Eastern Daylight Time CLAMART, France–(BUSINESS WIRE)–MicroPort CRM, a global pioneer in the field of Cardiac Rhythm Management, headquartered in France, announced today it […]
inHEART RECEIVES CE CERTIFICATION UNDER NEW MDR FOR NOVEL, AI-BASED, DIGITAL TWIN OF THE HEART
inHEART solution creates digital 3D models of the heart with unprecedented anatomical details, allowing physicians to better plan and personalize cardiac ablation procedures CAMBRIDGE, Mass. and PESSAC, France, May 18, 2023 /PRNewswire/ — inHEART, a privately-held medical device company delivering the world’s most advanced digital twin of the patient’s heart, announced today that it […]
New Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in Heart Failure Outcomes
Daxor’s BVA Technology Shown to Provide Unique and Individualized Data for Patient Management Oak Ridge, TN, May 18, 2023 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces new data demonstrating the importance and clinical utility of Daxor’s BVA-100 blood test in heart failure […]
Microbot Medical to Enhance Focus on its Core Business and Prioritize Preparations for Regulatory and First in Human Clinical Cases
Company will enable focus on its LIBERTY technology through the introduction of the Core Business Focus Program coupled with cost restructuring to support it HINGHAM, Mass., May 18, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic system, […]
Hyperfine, Inc. Receives Grant for an Additional Three Years to Utilize Innovative Swoop® Portable MR Imaging® System in Low and Middle-Income Countries
Clinical research, supported by funding from the Bill & Melinda Gates Foundation, has the potential to make a profound impact on global maternal and childhood health May 18, 2023 09:00 AM Eastern Daylight Time GUILFORD, Conn.–(BUSINESS WIRE)–Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, […]



